PharmacyCodes



Hydroserpine Plus (R-H-H) en es it fr

Hydroserpine Plus (R-H-H) Brand names, Hydroserpine Plus (R-H-H) Analogs

Hydroserpine Plus (R-H-H) Brand Names Mixture

  • Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
  • Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
  • SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)

Hydroserpine Plus (R-H-H) Chemical_Formula

C33H40N2O9

Hydroserpine Plus (R-H-H) RX_link

No information avaliable

Hydroserpine Plus (R-H-H) fda sheet

Hydroserpine Plus (R-H-H) msds (material safety sheet)

Hydroserpine_Plus_(R-H-H) MSDS

Hydroserpine Plus (R-H-H) Synthesis Reference

No information avaliable

Hydroserpine Plus (R-H-H) Molecular Weight

608.679 g/mol

Hydroserpine Plus (R-H-H) Melting Point

264.5 oC

Hydroserpine Plus (R-H-H) H2O Solubility

73 mg/L

Hydroserpine Plus (R-H-H) State

Solid

Hydroserpine Plus (R-H-H) LogP

3.32

Hydroserpine Plus (R-H-H) Dosage Forms

Tablets

Hydroserpine Plus (R-H-H) Indication

Foe the treatment of hypertension

Hydroserpine Plus (R-H-H) Pharmacology

Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.

Hydroserpine Plus (R-H-H) Absorption

No information avaliable

Hydroserpine Plus (R-H-H) side effects and Toxicity

Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg

Hydroserpine Plus (R-H-H) Patient Information

No information avaliable

Hydroserpine Plus (R-H-H) Organisms Affected

Humans and other mammals